HEALTHCARE GLOB. ENT. LTD Intrinsic Value
HCG · Healthcare · Current price ₹710.1
Is HEALTHCARE GLOB. ENT. LTD undervalued?
DocStoX estimates the fair value of HEALTHCARE GLOB. ENT. LTD at ₹203 per share, versus the current market price of ₹710. That puts the stock about -71.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹78), Relative P/E (₹60), Graham floor (₹43), Analyst target (₹822). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹43 (bear) to ₹203 (base) to ₹822 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹710 versus an intrinsic value of ₹203, HEALTHCARE GLOB. ENT. LTD currently offers -71.4% of negative margin (i.e. a premium).
More on HEALTHCARE GLOB. ENT. LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.